REQUEST A DEMO
Total
USD $0.00
Search more companies

Genomiks Yasam Bilimleri San. Ve Tic. Ltd. Sti. (Turkiye)

Main Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: Genomiks Yasam Bilimleri Sanayi Ve Ticaret Limited Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Genomiks Yasam Bilimleri San. Ve Tic. Ltd. Sti. is based in Turkiye. The head office is in Istanbul. It operates in the Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers industry. There are currently 21 (2023) people employed by Genomiks Yasam Bilimleri San. Ve Tic. Ltd. Sti.. The company’s latest financial report indicates a net sales revenue increase of 30.82% in 2021. Its total assets grew by 40.07% over the same period. In, 2021, the company’s net profit margin decreased by 1.43%.

Headquarters
Atakoy 9. Kisim A-19/a Blok No:19/a Atakoy 7-8-9-10. Kisim Mahallesi Hanimeli Cicegi Sokak Bakirkoy
Istanbul; Marmara; Postal Code: 34158

Contact Details: Purchase the Genomiks Yasam Bilimleri San. Ve Tic. Ltd. Sti. report to view the information.

Website: http://www.genomiks.com.tr

Basic Information
Total Employees:
Purchase the Genomiks Yasam Bilimleri San. Ve Tic. Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Genomiks Yasam Bilimleri San. Ve Tic. Ltd. Sti. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Genomiks Yasam Bilimleri San. Ve Tic. Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
30.82%
Total operating revenue
30.82%
Operating profit (EBIT)
93.14%
Net Profit (Loss) for the Period
-357.76%
Total assets
40.07%
Total equity
56.16%
Operating Profit Margin (ROS)
9.16%
Net Profit Margin
-1.43%
Return on Equity (ROE)
-2.35%
Debt to Equity Ratio
-34.35%
Quick Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?